Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.

V. L. Findlay; D. Zilberg; B. L. Munday

doi:10.1046/j.1365-2761.2000.00238.x

Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.

V. L. Findlay, D. Zilberg, B. L. Munday

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

Original language	English
Pages (from-to)	193-198
Number of pages	6
Journal	Journal of Fish Diseases
Volume	23
Issue number	3
DOIs	https://doi.org/10.1046/j.1365-2761.2000.00238.x
State	Published - 21 Oct 2000
Externally published	Yes

ASJC Scopus subject areas

Aquatic Science
Veterinary (miscellaneous)

Access to Document

10.1046/j.1365-2761.2000.00238.x

Cite this

@article{cf70e539a4134ff6a420560fae0b9b05,

title = "Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.",

abstract = "Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.",

author = "Findlay, {V. L.} and D. Zilberg and Munday, {B. L.}",

year = "2000",

month = oct,

day = "21",

doi = "10.1046/j.1365-2761.2000.00238.x",

language = "English",

volume = "23",

pages = "193--198",

journal = "Journal of Fish Diseases",

issn = "0140-7775",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "3",

}

TY - JOUR

T1 - Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.

AU - Findlay, V. L.

AU - Zilberg, D.

AU - Munday, B. L.

PY - 2000/10/21

Y1 - 2000/10/21

N2 - Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

AB - Levamisole, a known T-cell stimulator and immunomodulator in mammals, has been demonstrated to enhance resistance to amoebic gill disease in Atlantic salmon, Salmo salar L. When used in fresh water baths, dose rates of 1.25, 2.5 and 5 ppm levamisole stimulated resistance to reinfection with Paramoeba sp. that was evident from 2-3 weeks post-treatment. It is proposed that this response is related to enhancement of the non-specific immune system.

UR - http://www.scopus.com/inward/record.url?scp=0033810369&partnerID=8YFLogxK

U2 - 10.1046/j.1365-2761.2000.00238.x

DO - 10.1046/j.1365-2761.2000.00238.x

M3 - Article

AN - SCOPUS:0033810369

SN - 0140-7775

VL - 23

SP - 193

EP - 198

JO - Journal of Fish Diseases

JF - Journal of Fish Diseases

IS - 3

ER -

Evaluation of levamisole as a treatment for amoebic gill disease of Atlantic salmon, Salmo salar L.

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this